12 Best Dividend Paying Stocks to Buy Now

Page 7 of 10

4. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders: 95

Johnson & Johnson (NYSE:JNJ) is a major player in the pharmaceutical and medical device industries, with a recent market value close to $425 billion. The company is also showing growth, as second-quarter revenue increased 5.8% from the previous year and earnings rose 18%.

Until 2023, Johnson & Johnson (NYSE:JNJ) operated a strong consumer healthcare division that produced well-known products such as Tylenol and Band-Aid. That division was spun off into a separate company called Kenvue.

Johnson & Johnson (NYSE:JNJ)’s broad portfolio includes immunology treatments like Stelara and Tremfya, as well as cancer drugs such as Darzalex and Erleada. The company also has 40 programs currently in late-stage clinical trials. These trials are evaluating new drug candidates and seeking additional approvals for existing treatments like Stelara and Tremfya.

Johnson & Johnson (NYSE:JNJ) is popular among income investors because of its generous dividends. The company holds a 63-year track record of dividend growth, which makes it one of the best dividend paying stocks. Currently, it pays a quarterly dividend of $1.30 per share and has a dividend yield of 2.95%, as of September 19.

Page 7 of 10